Neurona Therapeutics

United States
South San Francisco, California, United States, 94080

Company profile

Neurona Therapeutics company profile

Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.

Business identity

Phone number
1 (650) 799-6465
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2008-04-01, Month

Headquarters

Postal code
94080
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
13
Total equity funding
$412.8M
Last funding
Grant / $14M / 2025-06-18
Last equity funding
Series F / $102M
Investors
24
Lead investors
7
Founders
2
Articles
108

Founders and investors

Founders

Arnold KriegsteinCory Nicholas

Lead investors

California Institute for Regenerative MedicineCormorant Asset ManagementNational Institutes of HealthSouth Carolina Research AuthorityThe Column GroupUCB VenturesViking Global Investors

Investors

Cormorant Asset ManagementFidelitySchroders CapitalSoleus CapitalSouth Carolina Research Authority